Last reviewed · How we verify
NCT05147025
Evaluation of Retreatment of Failed Revasculatized Teeth by Revascularization
NA trial testing Revascularization in Revascularization in 60 participants. Status unknown.
1 December 2023
Quick facts
| Lead sponsor | Minia University |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 60 |
| Start date | 1 December 2021 |
| Primary completion | 1 December 2023 |
| Estimated completion | 1 January 2024 |
Drugs / interventions tested
- Revascularization
Conditions studied
- Revascularization — all drugs for Revascularization →
Sponsor
Minia University
Who can join
Adults 8 to 10, any sex, with Revascularization. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Study will include 30 participants with failed revascularized young permenant teeth that will be retreated by revascularization and evaluated for success through 2 years
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05147025
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Revascularization
Trials testing the same drug.
- NCT06832839 — Study on the Mechanism of Cognitive Impairment in Patients with Moyamoya Disease · recruiting
- NCT06279663 — Management Tactics for Patients High Risk With Acute Coronary Syndrome Without ST Segment Elevation and Multivessel Coro · NA · recruiting
- NCT05644158 — Mitochondrial Function in Peripheral Arterial Disease · NA · unknown
- NCT05570019 — Evaluation of Tissue Perfusion in Peripheral Arterial Disease (EVTI-PAD) · unknown
- NCT04252950 — Community-based Exercise Following Revascularization for PAD · NA · recruiting
Other recruiting trials for Revascularization
Currently open trials in the same condition.
- NCT06686121 — Improving Mobility After Revascularization in Peripheral Artery Disease · Phase 3 · recruiting
- NCT06924593 — Study on the Trans-Carotid Artery Occlusion Shunt System · NA · recruiting
- NCT05532631 — Percutaneous Coronary RevascularizatiOn VERsus Coronary-Artery Bypass Grafting for Multivessel Disease in Patients With · NA · recruiting
- NCT05619068 — The Evolution and Prognosis of Moyamoya Disease · recruiting
- NCT05306119 — Developing a Method of Rehabilitation for Patients After Myocardial Revascularization · NA · active not recruiting
Other Minia University trials
Trials by the same sponsor.
- NCT07525687 — Temporary Uterine Tourniquet Application Versus Local Myometrial Epinephrine Injection During Laparoscopic Myomectomy · NA · not yet recruiting
- NCT07525674 — Vacuum Sealing Drainage (VSD) in Promoting Wound Healing and Reducing Complications in Post-Infected Obstetric and Gynec · NA · not yet recruiting
- NCT07529587 — Laparoscopic Umbilico-uterine Trunk Clipping Approach in the Management of Enhanced Myometrial Vascularity · NA · not yet recruiting
- NCT07500558 — Ultrasound Guided Infratemporal Sphenopalatine Ganglion Supravoltage Versus Standard Voltage Pulsed Radiofrequency for P · NA · not yet recruiting
- NCT07428057 — Postoperative Hypocalcemia After Thyroidectomy · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05147025 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Minia University
- Last refreshed: 7 December 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05147025.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing